David Beers - Feb 17, 2025 Form 4 Insider Report for Celularity Inc (CELU)

Role
Chief Financial Officer
Signature
/s/ David Beers
Stock symbol
CELU
Transactions as of
Feb 17, 2025
Transactions value $
-$9,407
Form type
4
Date filed
2/19/2025, 05:00 PM
Previous filing
Apr 16, 2024
Next filing
Apr 15, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CELU Class A Common Stock Options Exercise $0 +12.5K +132.53% $0.00 21.9K Feb 17, 2025 Direct F1
transaction CELU Class A Common Stock Tax liability -$9.41K -4.4K -20.04% $2.14 17.5K Feb 17, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CELU Restricted Stock Units Options Exercise $0 -12.5K $0.00 $0 Feb 17, 2025 Class A Common Stock 12.5K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock. On February 17, 2023, the reporting person was granted 12,500 RSUs, which vested on February 17, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on February 22,2023.
F2 This line reflects the tax withholding on the vesting of RSUs that vested on February 17, 2025.
F3 Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock.
F4 On February 17, 2023, the reporting person was granted 12,500 RSUs, which vested on February 17, 2025. The Class A Common Stock into which such vested RSUs converted on February 17, 2025 is reported in Table I on this Form 4.